Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-001281
Filing Date
2025-01-10
Accepted
2025-01-10 16:30:07
Documents
1
Period of Report
2025-01-08

Document Format Files

Seq Description Document Type Size
1 form4-01102025_040104.html 4  
1 form4-01102025_040104.xml 4 4136
  Complete submission text file 0001415889-25-001281.txt   5633
Mailing Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA GA 30005
Business Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA GA 30005 678-270-3631
Clearside Biomedical, Inc. (Issuer) CIK: 0001539029 (see all company filings)

EIN.: 452437375 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O CLEARSIDE BIOMEDICAL, INC. 900 NORTH POINT PARKWAY, SUITE 200 ALPHARETTA GA 30005
Business Address
Chong Ngai Hang Victor (Reporting) CIK: 0002014921 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37783 | Film No.: 25523399